India to Australia: Loperamide Export Trade Route
India has recorded 220 verified shipments of Loperamide exported to Australia, representing a combined trade value of $2.4M USD. This corridor is served by 21 active Indian exporters, with an average shipment value of $10.8K USD. The leading Indian exporter is MEDREICH LIMITED, which accounts for 29% of total export value with 74 shipments worth $701.2K USD. On the buying side, MEDREICH AUSTRALIA PTY LTD is the largest importer in Australia with $531.6K USD in purchases. The top 3 suppliers — MEDREICH LIMITED, SHARON BIO-MEDICINE LIMITED, SHARON BIO MEDICINE LIMITED — together control 66% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Australia Loperamide corridor is one of India's established pharmaceutical export routes, with 220 shipments documented worth a combined $2.4M USD. The route is dominated by MEDREICH LIMITED, which alone accounts for roughly 29% of all export value, reflecting the consolidated nature of India's loperamide manufacturing sector.
Across 21 active suppliers, the average shipment value stands at $10.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with loperamide's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 13.1%, placing it at rank #6 among India's top loperamide export destinations globally.
On the import side, key buyers of Indian loperamide in Australia include MEDREICH AUSTRALIA PTY LTD, ASPEN PHARMACARE AUSTRALIA PTY LTD, ASPEN PHARMACARE AUSTRALIA PTY LIMITED and 30 others. MEDREICH AUSTRALIA PTY LTD is the single largest importer with 56 shipments valued at $531.6K USD.
Route Characteristics
- Average transit24 days
- Peak seasonQ1
- Primary modeSea freight
- Top portBANGALORE ICD (INWFD6)
Market Position
- Global rank#6
- Annual growth+13.1%
- Demand growth+13.4%
- Regulatory ease89/100
Top 10 Indian Loperamide Exporters to Australia
Showing top 10 of 21 Indian suppliers exporting Loperamide to Australia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MEDREICH LIMITED Avg $9.5K per shipment | 74 | $701.2K | 29.4% |
| 2 | SHARON BIO-MEDICINE LIMITED Avg $14.0K per shipment | 41 | $573.3K | 24.1% |
| 3 | SHARON BIO MEDICINE LIMITED Avg $26.1K per shipment | 11 | $287.3K | 12.1% |
| 4 | MEDREICH LIMITED Avg $12.3K per shipment | 23 | $282.5K | 11.9% |
| 5 | SHARON BIO MEDICINE LTD Avg $30.4K per shipment | 4 | $121.5K | 5.1% |
| 6 | TENSHI KAIZEN PRIVATE LIMITED Avg $14.1K per shipment | 8 | $112.4K | 4.7% |
| 7 | MARKSANS PHARMA LIMITED Avg $6.4K per shipment | 15 | $95.3K | 4.0% |
| 8 | PROSFORA TECHNOLOGIES PRIVATE LIMITED Avg $7.5K per shipment | 6 | $44.7K | 1.9% |
| 9 | TENSHI KAIZEN PRIVATE LIMITED Avg $10.7K per shipment | 4 | $42.8K | 1.8% |
| 10 | MARKSANS PHARMA LIMITED Avg $7.3K per shipment | 5 | $36.3K | 1.5% |
This table shows the top 10 of 21 Indian companies exporting loperamide to Australia, ranked by total trade value. The listed exporters are: MEDREICH LIMITED, SHARON BIO-MEDICINE LIMITED, SHARON BIO MEDICINE LIMITED, MEDREICH LIMITED , SHARON BIO MEDICINE LTD, TENSHI KAIZEN PRIVATE LIMITED, MARKSANS PHARMA LIMITED, PROSFORA TECHNOLOGIES PRIVATE LIMITED, TENSHI KAIZEN PRIVATE LIMITED , MARKSANS PHARMA LIMITED . MEDREICH LIMITED is the dominant supplier with 74 shipments worth $701.2K USD, giving it a 29% market share. The top 3 suppliers together account for 66% of the total trade value on this route.
Showing top 10 of 21 total Indian exporters on the India to Australia Loperamide export route.
Top 10 Loperamide Importers in Australia
Showing top 10 of 33 known buyers in Australia receiving Loperamide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian loperamide in Australia include MEDREICH AUSTRALIA PTY LTD, ASPEN PHARMACARE AUSTRALIA PTY LTD, ASPEN PHARMACARE AUSTRALIA PTY LIMITED, MEDREICH AUSTRALIA PTY LTD , MEDREICH AUSTRALIA PTY LIMITED, among 33 total buyers. The largest importer is MEDREICH AUSTRALIA PTY LTD, accounting for $531.6K USD across 56 shipments — representing 22% of all loperamide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MEDREICH AUSTRALIA PTY LTD | 56 | $531.6K | 22.3% |
| 2 | ASPEN PHARMACARE AUSTRALIA PTY LTD | 27 | $465.0K | 19.5% |
| 3 | ASPEN PHARMACARE AUSTRALIA PTY LIMITED | 17 | $446.1K | 18.7% |
| 4 | MEDREICH AUSTRALIA PTY LTD | 22 | $271.1K | 11.4% |
| 5 | MEDREICH AUSTRALIA PTY LIMITED | 11 | $107.5K | 4.5% |
| 6 | NOVA PHARMACEUTICALS AUSTRALASIA | 12 | $87.0K | 3.7% |
| 7 | C/- LINFOX HEALTHCARE LOGISTICS, 27 | 12 | $71.1K | 3.0% |
| 8 | MYLAN AUSTRALIA PTY LIMITED | 7 | $62.1K | 2.6% |
| 9 | ARROW PHARMACEUTICALS PTY LIMITED | 4 | $57.8K | 2.4% |
| 10 | NEO HEALTH (OTC) PTY LTD | 6 | $44.7K | 1.9% |
Showing top 10 of 33 Loperamide importers in Australia on this route.
Top 10 Loperamide Formulations Imported by Australia
Showing top 10 of 136 product formulations shipped on the India to Australia Loperamide route, ranked by trade value
Australia imports a wide range of loperamide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — LOPERAMIDE CAPSULES 2MG (APO HEALTH DIAR — accounts for $89.6K USD across 6 shipments. There are 136 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | LOPERAMIDE CAPSULES 2MG (APO HEALTH DIAR | 6 | $89.6K | 3.8% |
| 2 | LOPERAMIDE HYDROCHLORIDE 2MG CAPSULES (G | 5 | $57.3K | 2.4% |
| 3 | Gastro Stop 2mg Capsules OTC-01x08'sLoperamide 2mg Capsule BATCH NO. AKX3023B MANUFACTURING .DT.09/2023 EXP.DT:08/2025 | 2 | $52.4K | 2.2% |
| 4 | LOPERAMIDE HYDROCHLORIDE CAPSULES BP 2MG | 8 | $49.6K | 2.1% |
| 5 | Gastro Stop 2mg Capsules OTC-02x10'sLoperamide 2mg Capsule BATCH NO. AKX3022A MANUFACTURING .DT.09/2023 EXP.DT:08/2025 | 1 | $46.8K | 2.0% |
| 6 | Gastro Stop 2mg Capsules OTC-02x10's Loperamide 2mg Capsule, BATCH NO. AKX3021A, MANUFACTURING .DT.09/2023, EXP.DT:08/2025 | 1 | $46.1K | 1.9% |
| 7 | GASTRO STOP 2MG CAPSULES (OTC)-02X10 S (LOPERAMIDE 2MG CAPSULE) BATCH NO.AKX3016A MFG.DT.07/2023 EXP.DT:06/2025 | 1 | $46.0K | 1.9% |
| 8 | GASTRO STOP 2MG CAPSULES (OTC)-02X10 S (LOPERAMIDE 2MG CAPSULE) BATCH NO.AKX3017A MFG.DT.08/2023 EXP.DT:07/2025 | 1 | $45.9K | 1.9% |
| 9 | GASTRO STOP 2MG CAPSULES (OTC)-02X10'S,(LOPERAMIDE 2MG CAPSULE), BATCH NO. AKX3028A, MFG.DT.11/2023, EXP.DT:10/2025 | 1 | $45.8K | 1.9% |
| 10 | Gastro Stop 2mg Capsules OTC-02x10'sLoperamide 2mg Capsule BATCH NO. AKX3024A MANUFACTURING .DT.10/2023 EXP.DT:09/2025 | 1 | $45.8K | 1.9% |
Showing top 10 of 136 Loperamide formulations imported by Australia on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 85%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
BANGALORE ICD (INWFD6) handles the highest volume with 45 shipments. Transit time averages 24 days by sea.
Market Dynamics
India's loperamide exports to Australia are driven primarily by a handful of large-scale manufacturers. MEDREICH LIMITED with 74 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 21 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MEDREICH LIMITED, SHARON BIO-MEDICINE LIMITED, SHARON BIO MEDICINE LIMITED — together account for 66% of total trade value on this route. The average shipment value of $10.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as loperamide hydrochloride 2mg capsules (g and gastro stop 2mg capsules otc-01x08'sloperamide 2mg capsule batch no. akx3023b manufacturing .dt.09/2023 exp.dt:08/2025, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, MEDREICH AUSTRALIA PTY LTD is the largest importer with 56 shipments worth $531.6K USD — representing 22% of all loperamide imports from India on this route. A total of 33 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $2.4M
- Avg. Shipment
- $10.8K
- Suppliers
- 21
- Buyers
- 33
- Transit (Sea)
- ~24 days
- Annual Growth
- +13.1%
Related Analysis
Other Loperamide Routes
Unlock the Full India to Australia Loperamide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 220 shipments on this route.
Frequently Asked Questions — India to Australia Loperamide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Loperamide to Australia?
The leading Indian exporters of Loperamide to Australia are MEDREICH LIMITED, SHARON BIO-MEDICINE LIMITED, SHARON BIO MEDICINE LIMITED. MEDREICH LIMITED holds the largest market share at approximately 29% of total trade value on this route.
Q What is the total value of Loperamide exports from India to Australia?
India exports Loperamide to Australia worth approximately $2.4M USD across 220 recorded shipments. The average value per shipment is $10.8K USD.
Q Which ports does India use to ship Loperamide to Australia?
The most active port of origin is BANGALORE ICD (INWFD6) with 45 shipments. Indian exporters primarily use sea freight for this route, with 85% of shipments going by sea and 30% by air.
Q How long does shipping take from India to Australia for Loperamide?
The average transit time for Loperamide shipments from India to Australia is approximately 24 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Australia Loperamide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 13.1% with demand growth tracking at 13.4%. The route is ranked #6 among India's top Loperamide export destinations globally.
Q How many suppliers are active on the India to Australia Loperamide route?
There are currently 21 active Indian suppliers exporting Loperamide to Australia. The market is moderately concentrated with MEDREICH LIMITED accounting for 29% of total shipment value.
Q Who are the main importers of Loperamide from India in Australia?
The leading importers of Indian Loperamide in Australia include MEDREICH AUSTRALIA PTY LTD, ASPEN PHARMACARE AUSTRALIA PTY LTD, ASPEN PHARMACARE AUSTRALIA PTY LIMITED, MEDREICH AUSTRALIA PTY LTD , MEDREICH AUSTRALIA PTY LIMITED. MEDREICH AUSTRALIA PTY LTD is the largest buyer with 56 shipments worth $531.6K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Australia export trade corridor identified from Indian Customs (DGFT) records for Loperamide.
- 2.Supplier/Buyer Matching: 21 Indian exporters and 33 importers in Australia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 220 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
220 Verified Shipments
21 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists